医学
宫颈癌
彭布罗利珠单抗
放化疗
肿瘤科
临床研究阶段
内科学
癌症
临床试验
免疫疗法
作者
Domenica Lorusso,Yang Xiang,K. Hasegawa,Giovanni Scambia,M.H. Leiva Galves,Pierre Elias,Andrés Acevedo,Júlia Vízkeleti,A.J.P.D.S. Gomes,Fernando Contreras Mejía,Allison B. Reiss,Asude Ayhan,J-Y. Lee,В. В. Саевец,Flora Zagouri,Ka Wan Li,K.U. Yamada,S. Toker,Sandro Pignata,Linda Duska
标识
DOI：10.1016/j.annonc.2023.10.032
摘要
Pembrolizumab (pembro) has shown efficacy in patients (pts) with cervical cancer. The effect of chemoradiotherapy may be enhanced by immunotherapy. ENGOT-cx11/GOG-3047/KEYNOTE-A18(NCT04221945) assessed the efficacy and safety of pembro + concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
蓝莓橘子酱
大力的灵雁
甜蜜的小小
2052669099
BowieHuang
苹果新蕾
归尘
sevenhill
友好的季节
橘x
GingerF
干净的琦
寻道图强
无极微光
ckeong89
贪玩的秋柔
小不点
互助
Stella
王伟轩
皖公网安备34019202002308
